Immuneering Corporation (IMRX) Operating cash flow 2020–2025
Immuneering Corporation (IMRX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$45.3MFY2025 · since FY2020: -$14.6M → -$45.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$45.3M | +17.6% |
| FY2024 | -$55.0M | -12.3% |
| FY2023 | -$49.0M | -11.0% |
| FY2022 | -$44.1M | -42.9% |
| FY2021 | -$30.9M | -111.0% |
| FY2020 | -$14.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice